The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Anaphylaxis-Anaphylactoid reaction (can be fatal)
Publications
Rocuronium-induced anaphylaxis: a case report.
JA clinical reports 2019 Dec 06;5;81 — 2019 Dec 06 — 81
[A Case of Rocuronium-induced Anaphylaxis in a Man with Kounis Syndrome in which Basophil Activation Test was Valuable in Determining the Causative Agent].
Masui. The Japanese journal of anesthesiology 2017 Apr;66;424-430 — 2017 Apr — 424-430
A Case of Rocuronium-Induced Anaphylactic Shock in an Asthmatic Child.
Anesthesia progress Spring 2018;65;58-59 — Spring 2018 — 58-59
Case of anaphylaxis induced by rocuronium treated with sugammadex.
Brazilian journal of anesthesiology (Elsevier) 2013 Nov-Dec;63;511 — 2013 Nov-Dec — 511
Multiple cross-reactivity to several types of neuromuscular blocking agents in a patient with rocuronium anaphylaxis.
Korean journal of anesthesiology 2013 Nov;65;473-4 — 2013 Nov — 473-4
Histaminoid reactions associated with rocuronium.
British journal of anaesthesia 2000 Jan;84;108-11 — 2000 Jan — 108-11
Anaphylactic reaction to rocuronium bromide.
Anaesthesia and intensive care 1996 Oct;24;601-4 — 1996 Oct — 601-4